Cargando…
Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases
New disease targets and medicinal chemistry approaches are urgently needed to develop novel therapeutic strategies for treating pulmonary diseases. Emerging evidence suggests that reduced activity of protein phosphatase 2A (PP2A), a complex heterotrimeric enzyme that regulates dephosphorylation of s...
Autores principales: | Yu, Howard, Zaveri, Sahil, Sattar, Zeeshan, Schaible, Michael, Perez Gandara, Brais, Uddin, Anwar, McGarvey, Lucas R., Ohlmeyer, Michael, Geraghty, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535831/ https://www.ncbi.nlm.nih.gov/pubmed/37763671 http://dx.doi.org/10.3390/medicina59091552 |
Ejemplares similares
-
Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration
por: Clark, Andrew R., et al.
Publicado: (2019) -
The S100 Protein Family as Players and Therapeutic Targets in Pulmonary Diseases
por: Sattar, Zeeshan, et al.
Publicado: (2021) -
Periodontal Diseases: Major Exacerbators of Pulmonary Diseases?
por: Kouanda, Bakey, et al.
Publicado: (2021) -
Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice
por: Park, Sangmi S., et al.
Publicado: (2023) -
Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus
por: Park, Sangmi S., et al.
Publicado: (2021)